|
|
||||||||
Technical Developments |
1 From the Department of Radiology, Osteoporosis and Arthritis Research Group (J.A.S., H.K.G.) and Department of Medicine and Epidemiology and Biostatistics (K.M.K., S.R.C.), University of California at San Francisco, 350 Parnassus Ave, Suite 607, San Francisco, CA 94143; Veterans Affairs Medical Center, San Francisco, Calif (K.M.K.); and Department of Radiology, UCSF/Mt Zion Medical Center, San Francisco, Calif (R.S.B.). From the 2000 RSNA scientific assembly. Received February 19, 2001; revision requested March 28; final revision received November 28; accepted December 10. Supported by Breast Cancer Research Program Concept Award DAMD17-00-1-0612 from the Department of Defense and by UCSF Academic Senate Committee on Research. Address correspondence to J.A.S. (e-mail: john.shepherd@oarg.ucsf.edu).
| ABSTRACT |
|---|
|
|
|---|
© RSNA, 2002
Index terms: Breast Breast neoplasms, 00.30 Cancer screening Phantoms
| INTRODUCTION |
|---|
|
|
|---|
Breast density was initially described with a semi-quantitative classification system that categorized breast density into one of four categories by taking into account the quantitative (amount) and qualitative (diffuse or pronounced ductal structures and dense parenchymal patterns) nature of the density (3,4,6,7).
A more quantitative approach is to measure the area of mammographically dense breast relative to the total projected breast area. In this article, we will refer to this as mammographic density (3,8,9). Mammographic density (10) is a quantitative continuous grading from 0% to 100% measured by means of delineating the radiographically dense areas on the mammogram from the entire breast area and providing a percentage of breast density. The percentage of breast density is calculated as follows: (high radiographic density area)/(total breast area) x 100. Although quantitative, this method is limited by the fact that films are calibrated for optical density, not mass density, and a unique threshold of breast density is selected by a reader for each image. In addition, the total and dense projected areas will change on the basis of the amount of breast compression. The reproducibility (coefficient of variation) of delineating dense regions combined with patient repositioning errors is generally approximately 5% or more (11). Therapy with tamoxifen, which reduces cancer risk, decreases breast density by 4.3% per year in patients with cancer (12). Thus, the sensitivity of the percentage of breast density in the prediction of risk of breast cancer or in the detection of response to therapy may be similar to that of categorical methods and insufficient to monitor therapeutic changes in breast density for individuals.
There are compelling reasons to use dual x-ray absorptiometry (DXA) techniques to measure breast composition: (a) DXA is the reference standard for measuring whole-body composition because of its low radiation dose and high accuracy and precision (13). (b) The precision and accuracy of DXA have been characterized in small animals that are less than 600 g (14), which is similar to the size of a human breast. (c) The technique does not require a subjective interpretation of results. (d) Breast compression is not required. (e) The technique is readily available throughout the world for measuring bone density and diagnosing osteoporosis. Our specific goals for this study were to calibrate a commercially available DXA device to measure breast glandular density, to quantify in vitro precision by using cadaveric breasts, and to compare our measurements with conventional mammographic density measurements.
| Materials and Methods |
|---|
|
|
|---|
Phantom Measurements
For this study, a phantom (M17; CIRS, Norfolk, Va) was used as a breast density calibration tool. This model is a density-step phantom of constant thickness that simulates different ratios of breast glandular tissue and adipose fat (Fig 1). This phantom is an approximate atomic equivalent to adipose fat and breast glandular tissue, as reported by Hammerstein et al (15). The phantoms attenuation coefficients are within 1% of their respective fat-gland ratios from 10 to 200 keV. The density ranged from 0% to 100% glandular density in six steps. The inner clear acrylic section was not included in our comparison, since acrylic is not a stable representation of tissue across a wide x-ray energy range. The phantom was scanned 10 times with the DXA scanner without repositioning, and the average percentage of fat value from each density step was determined.
|
For mammographic density, the films of the cadaveric breasts were acquired with a mammography machine (Sensorgraphe DMR; GE Medical Systems, Waukesha, Wis). The films were read by a trained radiologist, and the mammographically dense regions were delineated on the film with a wax pencil. The films were digitized at 100-µm spatial resolution with a digitizer (Lumisys 200; Lumisys, Sunnyvale, Calif). The mammographic density was then quantified by a research assistant with a workstation designed by Swarnakar et al (16) by tracing the pencil lines with a cursor.
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
It is of interest that the percentage of breast glandular tissue density does not equal one minus the percentage of fat. This is most likely, since the percentage of fat is measured relative to a two-compartment model of fat and muscle, not fat and glandular tissue. Even so, this relationship should result in a slope difference between the percentage of fat and the percentage of breast glandular tissue density. The offset is most likely caused by the DXA densitometer being calibrated to the in vivo four-compartment model of body composition. With this model, underwater weighing is used to derive body density, which has a known offset to absolute standards of fat and lean tissue (17). We expect the in vivo precision to be similar to the cadaveric precision with repositioning, since flipping the breast 180° would be a worst-case repositioning error.
There are other methods available to estimate body fat, but only DXA (18), computed tomography (CT) (19), and magnetic resonance (MR) imaging (20) can be used to measure the tissue composition of isolated body regions. Lee et al (20) reported a 2% accuracy of segmenting breast fat from glandular and ductal tissue in phantoms by using whole-breast MR imaging. The sections were individually segmented into two compartments, and measurements in all sections were summed to calculate a total percentage of breast fat. In 40 women, the SD of the mean value for the group was 18% compared with 30% for mammographic density in the same women, although the techniques were correlated (r = 0.6). This suggests that mammographic density is related to segmented compositional density but with a variance that is influenced by nondensity features.
CT can provide a precise measure of tissue composition calibrated to electron density or absolute references. Kalef-Ezra et al (19) described the normal breast electron density from CT volume scans in pre- and postmenopausal women. However, the whole-organ radiation dose with CT limits its usefulness as a screening tool. Neither technique, to the authors knowledge, has been used to quantify cancer risk on the basis of breast density.
Dual-energy mammographic imaging is not a new concept and has been used for selecting calcifications and for improving imaging contrast (2125). Breitenstein and Shaw (26) and Shaw and Plewes (27) reported on theoretical calculations of signal-to-noise ratios for single- versus dual-energy mammography to quantify tissue density with idealized phantoms. However, there is a substantial effort necessary to generate precise and accurate quantitative DXA images with standard mammography equipment (ie, filtering, poor dynamic range of film, availability of digital mammography units, x-ray tube stability). The widespread use of digital detectors and the replacement of x-ray film should make DXA imaging more feasible with standard digital mammography machines.
Our study had several limitations. First, there were only a small number of cadaveric breasts available for our estimates of precision and the regression analysis statistics. Second, we used a conventional DXA device optimized for bone density and whole-body composition measurements. In contrast to CT and the more specialized scanning modes possible with digital mammography machines, the DXA images acquired in this study have no diagnostic value beyond their use in determining tissue density and mass. Last, choosing alternative DXA energies may improve the techniques tissue selectivity even further.
In conclusion, findings of this study show that conventional DXA devices can be calibrated to measure the percentage of glandular density; with DXA, breast density can be quantified to approximately 1% precision limited principally by repositioning. The agreement between mammographic density and the percentage of breast glandular tissue density was moderately to highly correlated. Thus, compositional densitometry may be more accurate and precise than mammographic density for quantifying breast cancer risk. However, it has not been demonstrated whether compositional breast density measured by using any technique is more predictive or discriminating than mammographic density in determining breast cancer risk. In vivo studies to quantify the percentage of breast glandular tissue density and cancer risk are warranted.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Author contributions: Guarantor of integrity of entire study, J.A.S.; study concepts, J.A.S., K.K., S.R.C.; study design, J.A.S.; literature research, J.A.S., K.M.K.; experimental studies, J.A.S.; data acquisition, J.A.S., R.S.B.; data analysis/interpretation, R.S.B., K.M.K., J.A.S.; statistical analysis, J.A.S.; manuscript preparation, J.A.S., K.M.K.; manuscript definition of intellectual content, S.R.C., K.M.K., J.A.S., H.K.G.; manuscript editing, K.M.K.; manuscript revision/review, H.K.G., S.R.C., R.S.B.; manuscript final version approval, all authors.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P. R. Bakic, A.-K. Carton, D. Kontos, C. Zhang, A. B. Troxel, and A. D. A. Maidment Breast Percent Density: Estimation on Digital Mammograms and Central Tomosynthesis Projections Radiology, July 1, 2009; 252(1): 40 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Shepherd, S. Malkov, B. Fan, A. Laidevant, R. Novotny, and G. Maskarinec Breast Density Assessment in Adolescent Girls Using Dual-Energy X-ray Absorptiometry: A Feasibility Study Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1709 - 1713. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Harvey and V. E. Bovbjerg Quantitative Assessment of Mammographic Breast Density: Relationship with Breast Cancer Risk Radiology, January 1, 2004; 230(1): 29 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ziv, J. Shepherd, R. Smith-Bindman, and K. Kerlikowske RESPONSE: Re: Mammographic Breast Density and Family History of Breast Cancer J Natl Cancer Inst, November 19, 2003; 95(22): 1726 - 1727. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |